Recombinant Human SIRPA protein, C-hFc-Avi Tag, Biotinylated

Product Description

Cat

IMP-044

Official Symbol

SIRPA

Product Overview

Biotinylated Recombinant Human SIRPA protein(AA Glu 31-Arg 370)(Accession # P78324-1) is expressed from human 293 cells (HEK293). This protein carries a human IgG1 Fc tag at the C-terminus, followed by a Avi tag.

Expression System

HEK293

Species

Human

Tag

C-hFc-Avi Tag

Form

Lyophilized from sterile Tris with Glycine, Arginine and NaCl, pH7.5, 10% trehalose.

Conjugate

Biotinylated

Molecular Mass

The protein has a calculated MW of 65.8 kDa. The protein migrates as 75-105 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

Protein length

Glu 31-Arg 370

Endotoxin

Less than 1.0 EU per ug by the LAL method.

Purity

>95% as determined by SDS-PAGE.

Storage

For long term storage, the product should be stored at lyophilized state at -20°C or lower. Please avoid repeated freeze-thaw cycles. This product is stable after storage at: -20°C to -70°C for 12 months in lyophilized state; -70°C for 3 months under sterile conditions after reconstitution.

Reconstitution

It is recommended that sterile water be added to the vial to prepare a stock solution of 0.2 mg/ml. Centrifuge the vial at 4ºC before opening to recover the entire contents.

Bioactivity-FACS Title 2

Bioactivity-FACS

SDS-PAGE

Biotinylated Human SIRP alpha, Fc,Avitag on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 95%.

SEC-MALS 1

The purity of Biotinylated Human SIRP alpha, Fc,Avitag was more than 90% and the molecular weight of this protein is around 155-170 kDa verified by SEC-MALS.

Bioactivity-ELISA 1

Immobilized Human CD47, His Tag at 5 ug/mL (100 uL/well) can bind Biotinylated Human SIRP alpha, Fc,Avitag with a linear range of 5-205 ng/mL.

Bioactivity-ELISA 2

Serial dilutions of Anti-Human CD47 Neutralizing Antibody were added into Human CD47, Fc Tag: Biotinylated Human SIRP alpha, Fc,Avitag binding reactions. The half maximal inhibitory concentration (IC50) is 0.5431 ug/mL.

Bioactivity-FACS 1

FACS assay shows that Biotinylated Human SIRP alpha, Fc,Avitag can bind to Jurkat cell expressing CD47. The concentration of SIRP alpha used is 3 ug/mL.

Bioactivity-FACS 2

FACS analysis shows that the binding of Biotinylated Human SIRP alpha, Fc,Avitag to Jurkat expressing CD47 was inhibited by increasing concentration of neutralizing Anti- Human CD47 antibody. The concentration of SIRP alpha used is 1 ug/mL. IC50=0.1303 ug/mL.

Data Sheet MSDS

Datasheet MSDS

For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.

Online Inquiry